Top

Neuroradiology

Published in:

01-01-2013 | Diagnostic Neuroradiology

Regional cerebral perfusion in patients with Alzheimer’s disease and mild cognitive impairment: effect of APOE Epsilon4 allele

Authors: Sun Mi Kim, Min Ji Kim, Hak Young Rhee, Chang-Woo Ryu, Eui Jong Kim, Esben Thade Petersen, Geon-Ho Jahng

Published in: Neuroradiology | Issue 1/2013

Abstract

Introduction

The objective of this study was to evaluate the effect of apolipoprotein E (APOE) epsilon 4 allele on regional cerebral perfusion (rCBF) changes using arterial spin labeling (ASL) magnetic resonance imaging (MRI) in subjects who are carriers or noncarriers of this risk factor for Alzheimer disease (AD).

Methods

Twenty-five subjects with AD, 25 with amnestic mild cognitive impairment (MCI) and 25 cognitively normal (CN) subjects underwent isotropic volumetric T1-weighted imaging and pulsed ASL MRI. All subjects were divided into carrier or noncarriers of the epsilon4 allele. Voxel-based statistical analyses were performed among groups on rCBF by ANOVA tests. In each subject group, we also evaluated the rCBF change between carrier and noncarrier groups.

Results

rCBF was significantly reduced in AD subjects compared to other subjects. In CN and AD subjects, rCBF in the carrier group was significantly reduced in several areas of the brain compared with that of the noncarrier group. In the carrier group, rCBF was significantly increased in the right parahippocampal gyrus, the bilateral cingulate gyri and the right posterior cingulate on the MCI group in addition to the right superior frontal gyrus in the AD group.

Conclusion

rCBF in the CN and AD groups were significantly reduced in the subjects with the carriers of the epsilon4 allele, which is a risk factor for Alzheimer’s disease. In addition, rCBF in the MCI group was significantly increased in subjects who were carriers. Therefore, rCBF can be used as a biomarker to show disease progression in areas of the brain of MCI subjects.

Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS (2002) Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. NeuroImage 17(1):29–46PubMedCrossRef

Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O’Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F (2003) A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. NeuroImage 18(4):895–907PubMedCrossRef

Busatto GF, Diniz BS, Zanetti MV (2008) Voxel-based morphometry in Alzheimer’s disease. Expert Rev Neurother 8(11):1691–1702PubMedCrossRef

Jellinger KA (2006) Alzheimer 100—highlights in the history of Alzheimer research. J Neural Transm 113(11):1603–1623PubMedCrossRef

Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, Kepe V, Barrio JR (2008) Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 7(2):161–172PubMedCrossRef

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58(12):1985–1992PubMedCrossRef

Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH (2003) Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study: part 1. Arch Neurol 60(10):1385–1389PubMedCrossRef

Chua TC, Wen W, Slavin MJ, Sachdev PS (2008) Diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease: a review. Curr Opin Neurol 21(1):83–92PubMedCrossRef

Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2009) Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 250(3):856–866PubMedCrossRef

10.

Stahl R, Dietrich O, Teipel SJ, Hampel H, Reiser MF, Schoenberg SO (2007) White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 243(2):483–492PubMedCrossRef

11.

Luckhaus C, Flub MO, Wittsack HJ, Grass-Kapanke B, Janner M, Khalili-Amiri R, Friedrich W, Supprian T, Gaebel W, Modder U, Cohnen M (2008) Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer’s dementia by perfusion-weighted magnetic resonance imaging. NeuroImage 40(2):495–503PubMedCrossRef

12.

Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y (2008) Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer’s disease. J Cereb Blood Flow Metab 28(4):725–736PubMedCrossRef

13.

Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234(3):851–859PubMedCrossRef

14.

Bradley KM, O’Sullivan VT, Soper ND, Nagy Z, King EM, Smith AD, Shepstone BJ (2002) Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease. Brain 125(Pt 8):1772–1781PubMedCrossRef

15.

Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 60(8):1374–1377PubMedCrossRef

16.

Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, Wagenpfeil S, Minoshima S, Schwaiger M, Kurz A (2005) Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64(1):102–107PubMedCrossRef

17.

Mevel K, Desgranges B, Baron JC, Landeau B, De la Sayette V, Viader F, Eustache F, Chetelat G (2007) Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. NeuroImage 37(1):18–25PubMedCrossRef

18.

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923PubMedCrossRef

19.

Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW (1996) Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer’s disease. Window on molecular epidemiology. Ann N Y Acad Sci 777:158–165PubMedCrossRef

20.

Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ (2002) Cognitive change and the APOE epsilon 4 allele. Nature 418(6901):932PubMedCrossRef

21.

Nicoll JA, Savva GM, Stewart J, Matthews FE, Brayne C, Ince P (2011) Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathol Appl Neurobiol 37(3):285–294PubMedCrossRef

22.

Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR Jr (2010) Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol 67(3):308–316PubMed

23.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer’s disease. NeuroImage 44(3):724–728PubMedCrossRef

24.

Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H (2010) Effect of APOE epsilon4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis 21(3):947–966PubMed

25.

Tanaka S, Kawamata J, Shimohama S, Akaki H, Akiguchi I, Kimura J, Ueda K (1998) Inferior temporal lobe atrophy and APOE genotypes in Alzheimer’s disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies. Dement Geriatr Cogn Disord 9(2):90–98PubMedCrossRef

26.

Hogh P, Knudsen GM, Kjaer KH, Jorgensen OS, Paulson OB, Waldemar G (2001) Single photon emission computed tomography and apolipoprotein E in Alzheimer’s disease: impact of the epsilon4 allele on regional cerebral blood flow. J Geriatr Psychiatry Neurol 14(1):42–51PubMedCrossRef

27.

Kang Y, Na DL (eds) (2003) Seoul neuropsychological screening battery (SNSB). Human Brain Research & Consulting, Incheon

28.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56(3):303–308PubMedCrossRef

29.

Criteria for the clinical diagnosis of Alzheimer’s disease. Excerpts from the NINCDS-ADRDA Work Group report (1985). J Am Geriatr Soc 33 (1):2–3

30.

Golay X, Petersen ET, Hui F (2005) Pulsed star labeling of arterial regions (PULSAR): a robust regional perfusion technique for high field imaging. Magn Reson Med 53(1):15–21PubMedCrossRef

31.

Wang Z, Aguirre GK, Rao H, Wang J, Fernandez-Seara MA, Childress AR, Detre JA (2008) Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 26(2):261–269PubMedCrossRef

32.

Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin KP, Miller BL, Weiner MW, Schuff N (2006) Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 67(7):1215–1220PubMedCrossRef

33.

Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, Gibbs JM, Wise RJ, Hatazawa J, Herold S et al (1990) Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 113(Pt 1):27–47PubMedCrossRef

34.

Kim MJ, Jahng GH, Lee HY, Kim SM, Ryu CW, Shin WC, Lee SY (2010) Development of a Korean standard structural brain template in cognitive normals and patients with mild cognitive impairment and Alzheimer’s disease. J Korean Soc Magn Reson Med 14:103–114

35.

Jagust W, Thisted R, Devous MD Sr, Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N (2001) SPECT perfusion imaging in the diagnosis of Alzheimer’s disease: a clinical-pathologic study. Neurology 56(7):950–956PubMedCrossRef

36.

Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss WD (1998) Normal and pathological aging—findings of positron-emission-tomography. J Neural Transm 105(8–9):821–837PubMedCrossRef

37.

Sakamoto S, Matsuda H, Asada T, Ohnishi T, Nakano S, Kanetaka H, Takasaki M (2003) Apolipoprotein E genotype and early Alzheimer’s disease: a longitudinal SPECT study. J Neuroimaging 13(2):113–123PubMed

38.

Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ (2008) Hippocampal hyperperfusion in Alzheimer’s disease. NeuroImage 42(4):1267–1274PubMedCrossRef

39.

Luckhaus C, Cohnen M, Flubeta MO, Janner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Modder U, Wittsack HJ (2010) The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer’s dementia. Psychiatry Res 183(1):44–51PubMedCrossRef

40.

Hayasaka S, Du AT, Duarte A, Kornak J, Jahng GH, Weiner MW, Schuff N (2006) A non-parametric approach for co-analysis of multi-modal brain imaging data: application to Alzheimer’s disease. NeuroImage 30(3):768–779PubMedCrossRef

Title: Regional cerebral perfusion in patients with Alzheimer’s disease and mild cognitive impairment: effect of APOE Epsilon4 allele
Authors: Sun Mi Kim
Min Ji Kim
Hak Young Rhee
Chang-Woo Ryu
Eui Jong Kim
Esben Thade Petersen
Geon-Ho Jahng
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Neuroradiology / Issue 1/2013
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-012-1077-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Regional cerebral perfusion in patients with Alzheimer’s disease and mild cognitive impairment: effect of APOE Epsilon4 allele

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Lack of aneurysm formation after carotid artery ligation in rabbits: a polymer MICROFIL® study

New Year’s Greeting from the ESNR

Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis

Stents and flow diverters in the treatment of aneurysms: device deformation in vivo may alter porosity and impact efficacy

Dose–response relationship of locally applied nimodipine in an ex vivo model of cerebral vasospasm

Value of imaging lenticulostriate arteries before middle cerebral artery stenting for the prevention of perforator stroke